Manuel Aivado - 15 Jun 2021 Form 4 Insider Report for AILERON THERAPEUTICS INC (ALRN)

Role
President and Chief Executive Officer, Director
Signature
/s/ Richard Wanstall, attorney-in-fact for Manuel Aivado
Issuer symbol
ALRN
Transactions as of
15 Jun 2021
Transactions value $
$0
Form type
4
Filing time
17 Jun 2021, 19:56:40
Next filing
24 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRN Stock Option (right to buy) Award $0 +2.44M $0.00 2.44M 15 Jun 2021 Common Stock 2.44M $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest as to 25% of the shares on June 15, 2022 and thereafter in equal monthly installments through June 15, 2025.

Remarks:

President and Chief Executive Officer